Emergency rooms could be key to ending HIV: new study tests simple PrEP strategies
NCT ID NCT05588193
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two low-burden strategies to increase HIV PrEP use among emergency department patients seeking care for sexual health issues. One strategy involves follow-up outreach after the visit, while the other offers a tele-sexual health visit during the ER stay. The goal is to see which approach helps more at-risk patients start PrEP, a daily pill that prevents HIV.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral interventions (post-visit outreach and tele-sexual health visit)
What this could lead to
If successful, this could provide simple, effective ways to start HIV prevention medication for people who visit emergency rooms for sexual health concerns, helping reduce new HIV infections.
What could go wrong
This is an implementation study, not a drug trial, so it tests how to deliver existing prevention tools rather than a new cure. Results may vary across different communities and emergency departments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City University of New York - Hunter College
New York, New York, 10031, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States